Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma

Bone Marrow Transplant. 2018 Oct;53(10):1340-1344. doi: 10.1038/s41409-018-0184-7. Epub 2018 Apr 30.

Authors

Luxin Yang¹, Yamin Tan¹, Jimin Shi¹, Yanmin Zhao¹, Yuanyuan Zhu¹, Yongxian Hu¹, Wenjue Pan¹, Yishan Ye¹, Jingsong He¹, Weiyan Zheng¹, Jie Sun¹, Zhen Cai¹, He Huang¹, Yi Luo²

Affiliations

¹ Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
² Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China. luoyijr@zju.edu.cn.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Allografts
Disease-Free Survival
Female
Hematopoietic Stem Cell Transplantation*
Humans
Male
Middle Aged
Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality*
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
Remission Induction
Retrospective Studies
Survival Rate